Comparison between hypoxic markers pimonidazole and glucose transporter 1 (Glut-1) in murine fibrosarcoma tumours after electrochemotherapy

Kranjc S, Cemazar M, Grosel A, Sentjurc M, Sersa G. Radisensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells in tumors in mice. BMC Cancer 2005; 5: 115.10.1186/1471-2407-5-115Search in Google Scholar

Teicher BA. Acute and chronic in vivo therapeutic resistence. Biochem Pharmacol 2009; 77: 1665-73.10.1016/j.bcp.2009.01.006Search in Google Scholar

Rademakers SE, Span PN, Kaanders J, Swep F, van der Kogel AJ, Bussink J. Molecular aspects of tumour hypoxia. Mol Oncol 2008; 2: 41-53.10.1016/j.molonc.2008.03.006Search in Google Scholar

Mayer A, Höckel M, Wree A, Vaupel P. Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res 2004; 64: 5876-81.10.1158/0008-5472.CAN-03-3566Search in Google Scholar

Russell J, Carlin S, Burke SA, Wen B, Yang KM, Ling CC. Immunohistochemical detection of changes in tumor hypoxia. Int J Radiat Oncol Biol Phys 2009; 73: 1177-86.10.1016/j.ijrobp.2008.12.004Search in Google Scholar

Raleigh JA, Chou SC, Bono EL, Thral DE, Varia MA. Semiquantitative immunohistochemical analysis for hypoxia in human tumours. Int J Radiat Oncol Biol Phys 2001; 49: 569-74.10.1016/S0360-3016(00)01505-4Search in Google Scholar

Nordsmark M, Loncaster J, Chou SC, Hacsteen H, Lidegaard JC, Davidson SE, et al. Invasive oxygen measurements and pimonidazole labelling in human cervix carcinoma. Int J Radiat Oncol Biol Phys 2001; 49: 581-6.10.1016/S0360-3016(00)01493-0Search in Google Scholar

Sakata K, Someya M, Nagakura H, Nakata K, Oouchi A, Hareyama M, et al. A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes. Strahlenther Oncol 2006; 182: 511-7.10.1007/s00066-006-1532-x16944372Search in Google Scholar

Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. Regulation of glut-1 mRNA by hypoxia inducible factor-1. J Biol Chem 2001; 276: 9519-25.10.1074/jbc.M01014420011120745Search in Google Scholar

Cooper R, Sarioglu S, Sökmen S, Füzün M, Küpelioglu A, Valentine A, et al. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma. Br J Cancer 2003; 89: 870-6.10.1038/sj.bjc.6601202239448912942120Search in Google Scholar

Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008; 98: 388-98.10.1038/sj.bjc.6604168Search in Google Scholar

Sun X, Li XF, Russell J, Xing L, Urano M, Li GC, et al. Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dualtracer immunohistochemistry. Radiother Oncol 2008; 88: 269-76.10.1016/j.radonc.2008.05.015Search in Google Scholar

Airley RE, Philips RM, Evans AE, Double J, Burger AM, Feibig HH, et al. Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (first translational award) study of the relevance of tumour-hypoxia to the outcome of chemotherapy in human tumour derived xenografts. Int J Oncol 2005; 26: 1477-84.10.3892/ijo.26.6.1477Search in Google Scholar

Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, et al. Glut-1 and CAIX as intrinsic markers of hypoxial in carcinoma of the cervix: Relationship to pimonidazole binding. Int J Cancer 2003; 104: 85-91.10.1002/ijc.10904Search in Google Scholar

Jarm T, Sersa G, Miklavcic D. Oxygenation and blood flow in tumours treated with hydralazine: Evaluation with a novel luminescence-based fiberopric sensor. Technol Health 2002; 10: 363-80.10.3233/THC-2002-10501Search in Google Scholar

Kennedy AS, Raleigh JA, Perez GM, Calkins DP, Thrall DE, Novotny DB, et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys 1997; 37: 897-905.10.1016/S0360-3016(96)00539-1Search in Google Scholar

Olive PL, Durand RE, Raleigh JA, Luo C, Aquino-Parsons C. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. Br J Cancer 2000; 83: 1525-31.10.1054/bjoc.2000.1489236341011076663Search in Google Scholar

He F, Deng X, Wen B, Liu Y, Sun X, Xing L, et al. Nonivasive molecular imaging of hypoxia in human xenografrts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers. Cancer Res 2008; 68: 8597-606.10.1158/0008-5472.CAN-08-0677272401718922936Search in Google Scholar

Gulliksnud K, Vestvik IK, Galapathi K, Rofstad EK. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry. Radiol Res 2008; 170: 638-50.10.1667/RR1400.118959463Search in Google Scholar

Rajaganeshan R, Prased R, Guillou PJ, Poston G, Scott N, Jayne DG. The role of hypoxia in recurrence following resection of Dukes'B colorectal cancer. Int J Colorectal Dis 2008; 23: 1049-55.10.1007/s00384-008-0497-x18594846Search in Google Scholar

Yasuda M, Miyazawa M, Fujita M, Kajiwara H, Iida T, Hirasawa T, et al. Expression of hypoxia inducible factor 1-alfa (HAF-1alfa) and glucose transporter 1 (GLUT-1) in ovarian adenocarcinoma difference in hypoxic status depending on histological character. Oncol Rep 2008; 19: 111-6.Search in Google Scholar

Hoskin PJ, Sibtain A, Daley FM, Wilson GD. GLUT 1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 2003; 89: 1290-7.10.1038/sj.bjc.6601260239430914520462Search in Google Scholar

Kunkel M, Moergel M, Stockinger M, Joeng JH, Fritz G, Lehr HA, et al. Overexpression of Glut-1 is associated with resistence to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity. Oral Oncol 2007; 43: 796-803.10.1016/j.oraloncology.2006.10.00917207657Search in Google Scholar

Mayer A, Hockel M, Wree A, Vaupel P. Microregional expression of glucose transporter 1 and oxygenation status lack of correlation in locally advanced cervical cancer. Clin Cancer Res 2005; 11: 2768-73.10.1158/1078-0432.CCR-04-234415814659Search in Google Scholar

Hedley D, Pintilie M, Woo J, Morrison A, Birle D, Fyles A, et al. Carbonic anhidrase IXexpression, hypoxia, and progression in patients with uterin cervical carcinomas. Clin Cancer Res 2003; 9: 566-74.Search in Google Scholar

Jankovic B, Aquino-Persons C, Raleigh JA. Comparison between pimonidazole binding oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry 2006; 70B: 45-55.10.1002/cyto.b.2008616456867Search in Google Scholar

Koukourakis MI, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I, Gatter KC, et al. Hypoxia-actovated tumor pathways of angiogenesis and regulation of pH independent of anemia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 59: 67-71.10.1016/j.ijrobp.2003.10.01615093900Search in Google Scholar

Kostourou V, Troy H, Murray JF, Cullis ER, Whitley GS, Griffiths JR, et al. Overexpression of dimethylarginine dimethylaminohydrolase enhances tumour hypoxia: An insight into the relationship of hypoxia and angiogenesis in vivo. Neoplasia 2004; 6: 401-11.10.1593/neo.04109150210615256062Search in Google Scholar

Teissie J, Escoffre JM, Rols MP, Golzio M. Time dependence of electric field effects on cell membranes. A review for a critical selection of pulse duration for therapeutical applications. Radiol Oncol 2008; 42: 196-206.10.2478/v10019-008-0016-2Search in Google Scholar

Zupancic A, Corovic S, Miklavcic D. Optimization of electrode position and electric pulse amplitude in electrochemotherapy. Radiol Oncol 2008; 42: 93-101.Search in Google Scholar

Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, et al. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer 2002; 87: 1047-54.10.1038/sj.bjc.6600606236431412434299Search in Google Scholar